GM Chickens Developed to Lay Anti-cancer EggsFebruary 6, 2019
Scientists from Roslin Technologies in Edinburgh used genetic engineering to develop chickens that lay eggs with drugs for arthritis and some cancers. The drugs are estimated to be 100 times cheaper to produce when laid compared to those manufactured in factories.
According to Dr. Lissa Herron, one of the researchers, the chickens do not suffer and are even "pampered" compared to the handling of animals in farms. "As far as the chicken knows, it's just laying a normal egg. It doesn't affect its health in any way, it's just chugging away, laying eggs as normal," she added.
The new approach produces better yield and is proven to be more efficient and cost-effective compared to previous attempts. The researchers believe that in time, production can be scaled up to produce medicines for commercial distribution.
Read more from the Genetic Literacy Project.
See more articles:
News from Around the World
- FAO: Sustainable Agri Requires an Integrated Approach
- USDA ARS Female Biologist Bags NAS Food And Agricultural Science Prize
- SEARCA-BIC Policy Brief Analyzes the Cost of Regulatory Delays for GM Crops
- Scientists Sequence Genome of Broomcorn Millet
- Substance that Gives Rapeseed a Bitter Taste Has Been Discovered
- Near-complete Genome Sequence of Snapdragon Successfully Assembled
- Research Groups Discover How Plants Cope with Iron Deficiency
- Overexpression of Moss Gene in Cotton Enhances Yield and Fiber Quality
- Biofortified Cassava Shows Higher Levels of Iron
Plant Breeding Innovations
- CRISPR-Cas9 System Used to Develop First-Ever Plantain Resistant to Banana Streak Virus
- New CRISPR Database to Catalyze Collaborations
- Agrobacterium-delivered CRISPR-Cas9 System for Genome Editing of Wheat
Beyond Crop Biotech
- GM Chickens Developed to Lay Anti-cancer Eggs
From the BICs
- Communicating Scientific Issues Responsibly
- Genetic Biocontrol for Invasive Species
Subscribe to CBU: